Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong
· Delayed Price · Currency is HKD 6.22
+0.04 (0.65%)
Apr 29, 2026, 4:08 PM HKT
HKG:0719 Revenue
Shandong Xinhua Pharmaceutical Company had revenue of 2.42B CNY in the quarter ending March 31, 2026, a decrease of -0.28%. This brings the company's revenue in the last twelve months to 8.75B, up 3.88% year-over-year. In the year 2025, Shandong Xinhua Pharmaceutical Company had annual revenue of 8.75B with 3.41% growth.
Revenue (ttm)
8.75B CNY
Revenue Growth
+3.88%
P/S Ratio
0.97
Revenue / Employee
1.21M CNY
Employees
7,240
Market Cap
9.42B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.75B | 288.41M | 3.41% |
| Dec 31, 2024 | 8.47B | 365.47M | 4.51% |
| Dec 31, 2023 | 8.10B | 597.86M | 7.97% |
| Jan 1, 2023 | 7.50B | 942.91M | 14.37% |
| Dec 31, 2021 | 6.56B | 554.49M | 9.23% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Traditional Chinese Medicine Holdings Co. | 16.41B |
| Luye Pharma Group | 7.02B |
| Ab&B Bio-Tech CO., LTD. JS | 354.77M |
| Sihuan Pharmaceutical Holdings Group | 2.91B |
| China Shineway Pharmaceutical Group | 3.49B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 763.16M |
| Edding Genor Group Holdings | 2.77B |
| Xuanzhu Biopharmaceutical | 57.61M |
Shandong Xinhua Pharmaceutical Company News
- 2 months ago - Viral dance challenge lifted Chinese ibuprofen maker’s shares – now they are languishing - South China Morning Post